Live feed
Filing
SC 13D/A
SC 13D/A0001104659-20-040437·Akari Therapeutics Plc
Schedule 13D ownership disclosure
Akari Therapeutics Plc
Security class unavailable · CUSIP: 00972G108
Event date: 2019-07-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 28.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-040437
- Form type
- SC 13D/A
- Filer
- Akari Therapeutics Plc
- CIK
- CIK 1541157
- Filed
- Mar 30, 2020
- Reporting period
- Jul 03, 2019
- Description
- Schedule 13D beneficial ownership